The global Type-1 Diabetes Treatment market was valued at US$ 5020 million in 2023 and is anticipated to reach US$ 7034.4 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.

Type-1 Diabetes Treatment Market

Type-1 diabetes accounts for 5%–10% of all diabetes cases worldwide. Failure to produce insulin is the cause of this type of diabetes.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Type-1 Diabetes Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Type-1 Diabetes Treatment.

Report Scope

The Type-1 Diabetes Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Type-1 Diabetes Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Type-1 Diabetes Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Type-1 Diabetes Treatment Market Report

Report Metric	Details
Report Name	Type-1 Diabetes Treatment Market
Accounted market size in 2023	US$ 5020 million
Forecasted market size in 2030	US$ 7034.4 million
CAGR	4.5%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Rapid-Acting Insulin Short-Acting Insulin Others
Segment by Application	Hospitals & Clinics Academic & Research Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Astellas Pharma, Merck, Eli Lilly, Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim GmbH, Novartis, Pfizer Inc., Abbott Laboratories, Mannkind Corporation, Braun Melsungen AG, Macrogenics, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Type-1 Diabetes Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Type-1 Diabetes Treatment Market growing?

Ans: The Type-1 Diabetes Treatment Market witnessing a CAGR of 4.5% during the forecast period 2024-2030.

What is the Type-1 Diabetes Treatment Market size in 2030?

Ans: The Type-1 Diabetes Treatment Market size in 2030 will be US$ 7034.4 million.

Who are the main players in the Type-1 Diabetes Treatment Market report?

Ans: The main players in the Type-1 Diabetes Treatment Market are Astellas Pharma, Merck, Eli Lilly, Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim GmbH, Novartis, Pfizer Inc., Abbott Laboratories, Mannkind Corporation, Braun Melsungen AG, Macrogenics, Inc.

What are the Application segmentation covered in the Type-1 Diabetes Treatment Market report?

Ans: The Applications covered in the Type-1 Diabetes Treatment Market report are Hospitals & Clinics, Academic & Research Institutes

What are the Type segmentation covered in the Type-1 Diabetes Treatment Market report?

Ans: The Types covered in the Type-1 Diabetes Treatment Market report are Rapid-Acting Insulin, Short-Acting Insulin, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Type-1 Diabetes Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Rapid-Acting Insulin

1.2.3 Short-Acting Insulin

1.2.4 Others

1.3 Market by Application

1.3.1 Global Type-1 Diabetes Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals & Clinics

1.3.3 Academic & Research Institutes

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Type-1 Diabetes Treatment Market Perspective (2019-2030)

2.2 Type-1 Diabetes Treatment Growth Trends by Region

2.2.1 Global Type-1 Diabetes Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Type-1 Diabetes Treatment Historic Market Size by Region (2019-2024)

2.2.3 Type-1 Diabetes Treatment Forecasted Market Size by Region (2025-2030)

2.3 Type-1 Diabetes Treatment Market Dynamics

2.3.1 Type-1 Diabetes Treatment Industry Trends

2.3.2 Type-1 Diabetes Treatment Market Drivers

2.3.3 Type-1 Diabetes Treatment Market Challenges

2.3.4 Type-1 Diabetes Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Type-1 Diabetes Treatment Players by Revenue

3.1.1 Global Top Type-1 Diabetes Treatment Players by Revenue (2019-2024)

3.1.2 Global Type-1 Diabetes Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Type-1 Diabetes Treatment Revenue

3.4 Global Type-1 Diabetes Treatment Market Concentration Ratio

3.4.1 Global Type-1 Diabetes Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Type-1 Diabetes Treatment Revenue in 2023

3.5 Type-1 Diabetes Treatment Key Players Head office and Area Served

3.6 Key Players Type-1 Diabetes Treatment Product Solution and Service

3.7 Date of Enter into Type-1 Diabetes Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Type-1 Diabetes Treatment Breakdown Data by Type

4.1 Global Type-1 Diabetes Treatment Historic Market Size by Type (2019-2024)

4.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Type (2025-2030)

5 Type-1 Diabetes Treatment Breakdown Data by Application

5.1 Global Type-1 Diabetes Treatment Historic Market Size by Application (2019-2024)

5.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Type-1 Diabetes Treatment Market Size (2019-2030)

6.2 North America Type-1 Diabetes Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Type-1 Diabetes Treatment Market Size by Country (2019-2024)

6.4 North America Type-1 Diabetes Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Type-1 Diabetes Treatment Market Size (2019-2030)

7.2 Europe Type-1 Diabetes Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Type-1 Diabetes Treatment Market Size by Country (2019-2024)

7.4 Europe Type-1 Diabetes Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Type-1 Diabetes Treatment Market Size (2019-2030)

8.2 Asia-Pacific Type-1 Diabetes Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Type-1 Diabetes Treatment Market Size (2019-2030)

9.2 Latin America Type-1 Diabetes Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Type-1 Diabetes Treatment Market Size by Country (2019-2024)

9.4 Latin America Type-1 Diabetes Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Type-1 Diabetes Treatment Market Size (2019-2030)

10.2 Middle East & Africa Type-1 Diabetes Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Astellas Pharma

11.1.1 Astellas Pharma Company Detail

11.1.2 Astellas Pharma Business Overview

11.1.3 Astellas Pharma Type-1 Diabetes Treatment Introduction

11.1.4 Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2019-2024)

11.1.5 Astellas Pharma Recent Development

11.2 Merck

11.2.1 Merck Company Detail

11.2.2 Merck Business Overview

11.2.3 Merck Type-1 Diabetes Treatment Introduction

11.2.4 Merck Revenue in Type-1 Diabetes Treatment Business (2019-2024)

11.2.5 Merck Recent Development

11.3 Eli Lilly

11.3.1 Eli Lilly Company Detail

11.3.2 Eli Lilly Business Overview

11.3.3 Eli Lilly Type-1 Diabetes Treatment Introduction

11.3.4 Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2019-2024)

11.3.5 Eli Lilly Recent Development

11.4 Novo Nordisk

11.4.1 Novo Nordisk Company Detail

11.4.2 Novo Nordisk Business Overview

11.4.3 Novo Nordisk Type-1 Diabetes Treatment Introduction

11.4.4 Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2019-2024)

11.4.5 Novo Nordisk Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Detail

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Type-1 Diabetes Treatment Introduction

11.5.4 Sanofi Revenue in Type-1 Diabetes Treatment Business (2019-2024)

11.5.5 Sanofi Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Detail

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Type-1 Diabetes Treatment Introduction

11.6.4 AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2019-2024)

11.6.5 AstraZeneca Recent Development

11.7 Boehringer Ingelheim GmbH

11.7.1 Boehringer Ingelheim GmbH Company Detail

11.7.2 Boehringer Ingelheim GmbH Business Overview

11.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Introduction

11.7.4 Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2019-2024)

11.7.5 Boehringer Ingelheim GmbH Recent Development

11.8 Novartis

11.8.1 Novartis Company Detail

11.8.2 Novartis Business Overview

11.8.3 Novartis Type-1 Diabetes Treatment Introduction

11.8.4 Novartis Revenue in Type-1 Diabetes Treatment Business (2019-2024)

11.8.5 Novartis Recent Development

11.9 Pfizer Inc.

11.9.1 Pfizer Inc. Company Detail

11.9.2 Pfizer Inc. Business Overview

11.9.3 Pfizer Inc. Type-1 Diabetes Treatment Introduction

11.9.4 Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2019-2024)

11.9.5 Pfizer Inc. Recent Development

11.10 Abbott Laboratories

11.10.1 Abbott Laboratories Company Detail

11.10.2 Abbott Laboratories Business Overview

11.10.3 Abbott Laboratories Type-1 Diabetes Treatment Introduction

11.10.4 Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2019-2024)

11.10.5 Abbott Laboratories Recent Development

11.11 Mannkind Corporation

11.11.1 Mannkind Corporation Company Detail

11.11.2 Mannkind Corporation Business Overview

11.11.3 Mannkind Corporation Type-1 Diabetes Treatment Introduction

11.11.4 Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2019-2024)

11.11.5 Mannkind Corporation Recent Development

11.12 Braun Melsungen AG

11.12.1 Braun Melsungen AG Company Detail

11.12.2 Braun Melsungen AG Business Overview

11.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Introduction

11.12.4 Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2019-2024)

11.12.5 Braun Melsungen AG Recent Development

11.13 Macrogenics, Inc.

11.13.1 Macrogenics, Inc. Company Detail

11.13.2 Macrogenics, Inc. Business Overview

11.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Introduction

11.13.4 Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2019-2024)

11.13.5 Macrogenics, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Boehringer Ingelheim GmbH

List of Tables

Table 1. Global Type-1 Diabetes Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Rapid-Acting Insulin

Table 3. Key Players of Short-Acting Insulin

Table 4. Key Players of Others

Table 5. Global Type-1 Diabetes Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Type-1 Diabetes Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Type-1 Diabetes Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Type-1 Diabetes Treatment Market Share by Region (2019-2024)

Table 9. Global Type-1 Diabetes Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Type-1 Diabetes Treatment Market Share by Region (2025-2030)

Table 11. Type-1 Diabetes Treatment Market Trends

Table 12. Type-1 Diabetes Treatment Market Drivers

Table 13. Type-1 Diabetes Treatment Market Challenges

Table 14. Type-1 Diabetes Treatment Market Restraints

Table 15. Global Type-1 Diabetes Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Type-1 Diabetes Treatment Market Share by Players (2019-2024)

Table 17. Global Top Type-1 Diabetes Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type-1 Diabetes Treatment as of 2023)

Table 18. Ranking of Global Top Type-1 Diabetes Treatment Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Type-1 Diabetes Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Type-1 Diabetes Treatment Product Solution and Service

Table 22. Date of Enter into Type-1 Diabetes Treatment Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Type-1 Diabetes Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2019-2024)

Table 26. Global Type-1 Diabetes Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2025-2030)

Table 28. Global Type-1 Diabetes Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Type-1 Diabetes Treatment Revenue Market Share by Application (2019-2024)

Table 30. Global Type-1 Diabetes Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Type-1 Diabetes Treatment Revenue Market Share by Application (2025-2030)

Table 32. North America Type-1 Diabetes Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Type-1 Diabetes Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Type-1 Diabetes Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Type-1 Diabetes Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Type-1 Diabetes Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Type-1 Diabetes Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Type-1 Diabetes Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Type-1 Diabetes Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Type-1 Diabetes Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Type-1 Diabetes Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Type-1 Diabetes Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 47. Astellas Pharma Company Detail

Table 48. Astellas Pharma Business Overview

Table 49. Astellas Pharma Type-1 Diabetes Treatment Product

Table 50. Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)

Table 51. Astellas Pharma Recent Development

Table 52. Merck Company Detail

Table 53. Merck Business Overview

Table 54. Merck Type-1 Diabetes Treatment Product

Table 55. Merck Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)

Table 56. Merck Recent Development

Table 57. Eli Lilly Company Detail

Table 58. Eli Lilly Business Overview

Table 59. Eli Lilly Type-1 Diabetes Treatment Product

Table 60. Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)

Table 61. Eli Lilly Recent Development

Table 62. Novo Nordisk Company Detail

Table 63. Novo Nordisk Business Overview

Table 64. Novo Nordisk Type-1 Diabetes Treatment Product

Table 65. Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)

Table 66. Novo Nordisk Recent Development

Table 67. Sanofi Company Detail

Table 68. Sanofi Business Overview

Table 69. Sanofi Type-1 Diabetes Treatment Product

Table 70. Sanofi Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)

Table 71. Sanofi Recent Development

Table 72. AstraZeneca Company Detail

Table 73. AstraZeneca Business Overview

Table 74. AstraZeneca Type-1 Diabetes Treatment Product

Table 75. AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)

Table 76. AstraZeneca Recent Development

Table 77. Boehringer Ingelheim GmbH Company Detail

Table 78. Boehringer Ingelheim GmbH Business Overview

Table 79. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product

Table 80. Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)

Table 81. Boehringer Ingelheim GmbH Recent Development

Table 82. Novartis Company Detail

Table 83. Novartis Business Overview

Table 84. Novartis Type-1 Diabetes Treatment Product

Table 85. Novartis Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)

Table 86. Novartis Recent Development

Table 87. Pfizer Inc. Company Detail

Table 88. Pfizer Inc. Business Overview

Table 89. Pfizer Inc. Type-1 Diabetes Treatment Product

Table 90. Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)

Table 91. Pfizer Inc. Recent Development

Table 92. Abbott Laboratories Company Detail

Table 93. Abbott Laboratories Business Overview

Table 94. Abbott Laboratories Type-1 Diabetes Treatment Product

Table 95. Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)

Table 96. Abbott Laboratories Recent Development

Table 97. Mannkind Corporation Company Detail

Table 98. Mannkind Corporation Business Overview

Table 99. Mannkind Corporation Type-1 Diabetes Treatment Product

Table 100. Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)

Table 101. Mannkind Corporation Recent Development

Table 102. Braun Melsungen AG Company Detail

Table 103. Braun Melsungen AG Business Overview

Table 104. Braun Melsungen AG Type-1 Diabetes Treatment Product

Table 105. Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)

Table 106. Braun Melsungen AG Recent Development

Table 107. Macrogenics, Inc. Company Detail

Table 108. Macrogenics, Inc. Business Overview

Table 109. Macrogenics, Inc. Type-1 Diabetes Treatment Product

Table 110. Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2019-2024) & (US$ Million)

Table 111. Macrogenics, Inc. Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Type-1 Diabetes Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Type-1 Diabetes Treatment Market Share by Type: 2023 VS 2030

Figure 3. Rapid-Acting Insulin Features

Figure 4. Short-Acting Insulin Features

Figure 5. Others Features

Figure 6. Global Type-1 Diabetes Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Type-1 Diabetes Treatment Market Share by Application: 2023 VS 2030

Figure 8. Hospitals & Clinics Case Studies

Figure 9. Academic & Research Institutes Case Studies

Figure 10. Type-1 Diabetes Treatment Report Years Considered

Figure 11. Global Type-1 Diabetes Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Type-1 Diabetes Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Type-1 Diabetes Treatment Market Share by Region: 2023 VS 2030

Figure 14. Global Type-1 Diabetes Treatment Market Share by Players in 2023

Figure 15. Global Top Type-1 Diabetes Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type-1 Diabetes Treatment as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Type-1 Diabetes Treatment Revenue in 2023

Figure 17. North America Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Type-1 Diabetes Treatment Market Share by Country (2019-2030)

Figure 19. United States Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Type-1 Diabetes Treatment Market Share by Country (2019-2030)

Figure 23. Germany Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Type-1 Diabetes Treatment Market Share by Region (2019-2030)

Figure 31. China Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Type-1 Diabetes Treatment Market Share by Country (2019-2030)

Figure 39. Mexico Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Type-1 Diabetes Treatment Market Share by Country (2019-2030)

Figure 43. Turkey Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Type-1 Diabetes Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Astellas Pharma Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)

Figure 46. Merck Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)

Figure 47. Eli Lilly Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)

Figure 48. Novo Nordisk Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)

Figure 49. Sanofi Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)

Figure 50. AstraZeneca Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)

Figure 51. Boehringer Ingelheim GmbH Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)

Figure 52. Novartis Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)

Figure 53. Pfizer Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)

Figure 54. Abbott Laboratories Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)

Figure 55. Mannkind Corporation Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)

Figure 56. Braun Melsungen AG Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)

Figure 57. Macrogenics, Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions